VIITAL Trademark

Trademark Overview

On Monday, September 19, 2022, a trademark application was filed for VIITAL with the United States Patent and Trademark Office. The USPTO has given the VIITAL trademark a serial number of 97596771. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, October 16, 2024. This trademark is owned by Abeona Therapeutics Inc.. The VIITAL trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing pharmaceutical information on the efficacy of a gene therapy preparation for the treatment of recessive dystrophic epidermolysis bullosa
viital

General Information

Serial Number97596771
Word MarkVIITAL
Filing DateMonday, September 19, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements

Description of MarkThe mark consists of the word VIITAL with the VII in green and the TAL in blue. The color white represents background and is not claimed as a feature of the mark.
Indication of Colors claimedThe color(s) green and blue is/are claimed as a feature of the mark.
Goods and ServicesProviding pharmaceutical information on the efficacy of a gene therapy preparation for the treatment of recessive dystrophic epidermolysis bullosa

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbeona Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameAbeona Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events

Event DateEvent Description
Thursday, September 22, 2022NEW APPLICATION ENTERED
Tuesday, October 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 29, 2023ASSIGNED TO EXAMINER
Friday, July 7, 2023NON-FINAL ACTION WRITTEN
Friday, July 7, 2023NON-FINAL ACTION E-MAILED
Friday, July 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 16, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 16, 2024SOU EXTENSION 2 FILED
Wednesday, October 16, 2024SOU EXTENSION 2 GRANTED
Wednesday, October 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 10, 2024SOU EXTENSION 1 GRANTED
Wednesday, April 10, 2024SOU EXTENSION 1 FILED
Thursday, April 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

viital recessive treatment dystrophic epidermolysis bullosa preparation therapy pharmaceutical information efficacy